Virus Inactivation in the 1990s ? and into the 21st Century Part 3a, Plasma and Plasma Products (Heat and Solvent/Detergent Treatments)

Sofer,Gail;

Publication

Article

April 15, 2002

BioPharm International

BioPharm International-09-01-2002

Volume15

Issue 9

Virus Inactivation in the 1990s ? and into the 21st Century Part 3a, Plasma and Plasma Products (Heat and Solvent/Detergent Treatments)

Author(s):

Gail Sofer

by Gail Sofer, BioReliance Plasma products have been associated with high levels of risk from viral contamination; therefore, most viral inactivation methods described in the literature during the past ten years have addressed plasma and plasma products. Plasma is the largest group to cover, and Part 3 takes two articles in our series to describe the many methods published. This article covers heat and solvent/detergent inactivation treatments for plasma.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration

Reexamining the Set It and Forget It Approach

Controlled Clean Environment Enclosures: A Cost-Effective Alternative to Cleanrooms

Security in the Corporate Homeland

Integrating New Technology into Blood Plasma Fractionation

Attack Mounts on Pharmaceutical Prices

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!